POLYCLONAL ANTIBODIES AGAINST RAT PITUITARY HORMONES

抗大鼠垂体激素的多克隆抗体

• 批准号: 2307151
• 负责人: ALBERT F PARLOW
• 金额: $ 21.13万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-11-26 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/2307151
• 关键词: POLYCLONAL; ANTIBODIES; AGAINST; RAT; PITUITARY

The Contractor shall be responsible for producing distinct polyclonal antibodies directed against the following rat pituitary hormones and subunits: rat growth hormone (rGH); rat prolactin (rPRL); rat thyroid stimulating hormone (rTSH); and its alpha and beta subunits; rat leutinizing hormone (rLH) and its alpha and beta subunits; and rat follicle stimulating hormone (rFSH) and its alpha and beta subunits. The Contractor shall make arrangements for obtaining experimental animals in which the polyclonal antibodies will be generated against highly purified preparations of the specified hormones and subunits.

承包商应负责产生不同的多克隆 针对以下大鼠垂体激素的抗体和 亚基：大鼠生长激素（RGH）；大鼠催乳素（RPRL）;大鼠甲状腺 刺激激素（RTSH）；及其Alpha和Beta亚基；鼠 Leutinized激素（RLH）及其α和β亚基；和大鼠卵泡 刺激激素（RFSH）及其α和β亚基。 承包商 应安排获得实验动物 多克隆抗体将针对高度纯化产生 指定激素和亚基的制备。